Clearmind Medicine Inc. (CMND)
Develops psychedelic medicines to treat alcohol addiction, eating disorders, and depression.
$1.46-0.09%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-99.6%
The outlook
CMND is trading near its 52-week low with price well below both its 50- and 200-day moving averages, signaling a weak downtrend. Analyst coverage appears thin or unavailable. The overall sentiment leans bearish based on current technical positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.2M
52-wk high
$524.00
52-wk low
$1.43
50-day avg
$2.67
200-day avg
$60.45
Trailing P/E
—